Michele Provenzano

Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial

Michele Provenzano, María Jesús Puchades, Carlo Garofalo et al. · Journal of the American Society of Nephrology · 2022 · 176 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies

Roberto Minutolo, Francis B. Gabbai, Michele Provenzano et al. · Nephrology Dialysis Transplantation · 2018 · 91 citations · Full text

Medicine, Internal Medicine, Nephrology +17

The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

Michele Provenzano, Niels Jongs, Priya Vart et al. · Kidney International Reports · 2021 · 91 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies

Roberto Minutolo, Francis B. Gabbai, Paolo Chiodini et al. · American Journal of Kidney Diseases · 2019 · 88 citations

Medicine, Geriatric Medicine, Nephrology +16

Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile

Michele Provenzano, Laura Rivoli, Carlo Garofalo et al. · PLoS ONE · 2020 · 83 citations · Full text

Medicine, Nephrology, Dialysis +16